CanniMed Therapeutics Inc reports results for Q3 2017
Saskatchewan-based CanniMed Therapeutics (TSX:CMED), producer of pesticide-free cannabis products, reported 3-month and 9-month financial results ending July 31, 2017. 3Q revenue of C$4.8M was 80% higher than the year ago figure of C$2.6M. Nine-month revenue of $11.9M was 79% higher than year ago of $6.6M.
The company sold 463kg at an average price of $9.89 per grams. Concentrate sales were 57% of the total revenue. Adjusted EBITDA was a loss of C$0.3M for the quarter. The net loss of C$1.4M included a $2.3M loss on derivative instruments, not related to operations.
In its results, the company also reported that it:
– began design of a large cannabinoid processing facility to increase its oils production.
– completed installation of capsule manufacturing equipment with capacity of up to
11,000 capsules per hour
– continued negotiations with several Canadian pharmacy chains
– completed first shipments of commercial cannabis to Australia
– targeted production of 17,000 to 21,000 kg per annum within 24 months
The company is expanding its main facility in Saskatoon, developing export opportunities and considering entering the recreational market.
The stock traded up 1.69% to C$9.00 on volume of 74k shares. Its 52-week range is $7.320 – $13. 35. The stock is up 25% from its low of $7.20 in late June.
Source: Cannimed press release
CanniMed Therapeutics Inc reports results for Q3 2017
About Cannin.com: Your Marijuana Stocks Resource
Cannin is your #1 resource for marijuana stocks. Our global team of experts evaluates all emerging marijuana stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best marijuana stock investments for 2020.
Use Cannin as your resource for:
- Cannabis and hemp investing news
- Featured cannabis and hemp company analysis
- Comprehensive cannabis and hemp stock reports
Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Many market analysts expect the legal marijuana industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in marijuana stocks is now.
Are you interested in marijuana stocks like Curaleaf, Trulieve, Aurora Cannabis, or Charlotte’s Web,?
Are you looking to buy stock in marijuana companies for 2020? Interested in emerging penny marijuana stocks? Looking for the best Canadian marijuana stocks to invest in? We can help.
Predict price movements of marijuana stocks several hours in advance with our proprietary algorithmic stock trading software.
- +25% Gains in 2020
- +49.8% Gains in 2019
- 108% Backtested since 2012
We’re so confident you’ll love our algotrading marijuana stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.
Profit from the best marijuana stocks – we’ll show you how at cannin.com.
Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks 2020
